PAR 0.75% $2.65 paradigm biopharmaceuticals limited..

Fifty One Capital updated report

  1. 1,117 Posts.
    lightbulb Created with Sketch. 180
    FiftyOne Capital have just updated their research report on PAR and upgraded outlook with the in-licensing of MPS, and release of substantial additional SAS data since the latest report.

    http://www.fiftyonecapital.com/market-insights/2018/11/24/paradigm-biopharmaceuticals-ltd

    There is a lot in there to digest!  Some really interesting comparisons with other trials, drugs and statistics that support the bull case and the near certain success of the P2 trial.  Interesting comparators on deal sizes as a function of market size, to support some very high valuations from here....
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
$2.65
Change
-0.020(0.75%)
Mkt cap ! $515.7M
Open High Low Value Volume
$2.70 $2.70 $2.57 $818.8K 310.8K

Buyers (Bids)

No. Vol. Price($)
4 19702 $2.65
 

Sellers (Offers)

Price($) Vol. No.
$2.66 4482 5
View Market Depth
Last trade - 15.34pm 24/10/2019 (20 minute delay) ?
(live)
Last
$2.65
  Change
-0.020 ( 0.09 %)
Open High Low Volume
$2.61 $2.70 $2.56 44905
Last updated 15.56pm 24/10/2019 (live) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.